浙江健新原力制药有限公司

ENABLING ATMP
GLOBAL COMMERCIAL
SUCCESS

ONE-STOP CDMO FOR
PLASMID, RNA, LNP, EXOSOMES AND VIRAL VECTORS

ABOUT US +

Innoforce is a premier CDMO focusing on Advanced Therapy Medicinal Products (“ATMP”). We have developed comprehensive technology platforms to enable end-to-end manufacture of high-quality plasmid DNA, RNA, LNP, exosomes, viral vectors, and cell therapeutics. Our state-of-the-art facility is designed to meet the cGMP standards of the FDA, EMA, and NMPA. We have also implemented rigorous policies and procedures to safeguard our clients’ IP. Innoforce is led by an industry-seasoned management team with extensive experience leading multiple innovative products from development to commercialization in the US, EU, and China. Our goal is to accelerate the development and commercialization of innovative products globally. With our expertise in process development and manufacturing, Innoforce can be a trusted partner from R&D through commercialization.

LEARN MORE

BUSINESS MODALITIES +

Plasmid DNA

RNA IVT

LNP Encapsulation

Viral Vectors

Plasmid DNA

Plasmid DNA is a starting material for advanced therapy medicinal products (ATMP), including RNA therapy, viral vector-based cell therapy and gene therapy. Innoforce has a broad-spectrum of proprietary technologies in development and manufacturing of plasmid DNA. We offer different grades and services to support your programs from pre-clinical phase through clinical and commercial phases.

LEARN MORE

RNA IVT

The rapid advances in mRNA technology enable the introduction of any functional proteins into the human body, bringing great hope to combat a wide range of incurable diseases. Innoforce integrates innovation and accumulated experience to deliver best-in-class mRNA products and streamline the development of your mRNA therapeutics.

LEARN MORE

LNP Encapsulation

The instability of the mRNA structure makes it easy to degrade in vivo. Lipid nanoparticles (LNP) are one of the most commonly used delivery systems that allow mRNA to release safely and effectively in target organs. With years of dedication to developing LNP delivery systems, Innoforce possesses a series of proprietary technologies and robust manufacturing processes.

LEARN MORE

Viral Vectors

As a technical-driven CDMO, we are committed to delivering innovative technologies and scale-up knowledge to bring reliable and high-quality products to clients. Our expertise in viral vector manufacturing addresses challenges in purification, scaling up and control, and we share in-depth knowledge across different viral vectors, including lentiviral vectors, AAV and retrovirus.

LEARN MORE